Position in EYPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,661,714
-$39,004 QoQ
Shares Held
116,204
-11.9% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 188 holders
Holding Since
Sep 2021
14 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. EYPT ranks #123 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in EYPT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,661,714 | 116,204 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,700,718 | 131,941 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $6,193,602 | 339,004 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $4,141,248 | 290,818 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,211,742 | 128,772 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $232,776 | 42,948 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $116,643 | 15,657 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $107,703 | 13,480 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $119,162 | 13,697 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,221,095 | 252,593 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,663,836 | 288,353 | Shares | Defined | 2024-02-13 | |
| 2022-03-31 | $1,591,637 | 130,999 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,680,980 | 137,335 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,776,025 | 170,444 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||